KHTRF
Price
$4.66
Change
+$0.11 (+2.42%)
Updated
Aug 7 closing price
Capitalization
450.67M
LVRLF
Price
$0.06
Change
+$0.01 (+20.00%)
Updated
Aug 15 closing price
Capitalization
6.56M
78 days until earnings call
Interact to see
Advertisement

KHTRF vs LVRLF

Header iconKHTRF vs LVRLF Comparison
Open Charts KHTRF vs LVRLFBanner chart's image
Knight Therapeutics
Price$4.66
Change+$0.11 (+2.42%)
Volume$520
Capitalization450.67M
CordovaCann
Price$0.06
Change+$0.01 (+20.00%)
Volume$6.74K
Capitalization6.56M
KHTRF vs LVRLF Comparison Chart in %
Loading...
KHTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LVRLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KHTRF vs. LVRLF commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KHTRF is a Buy and LVRLF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (KHTRF: $4.66 vs. LVRLF: $0.06)
Brand notoriety: KHTRF and LVRLF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: KHTRF: 19% vs. LVRLF: 17%
Market capitalization -- KHTRF: $450.67M vs. LVRLF: $6.56M
KHTRF [@Pharmaceuticals: Generic] is valued at $450.67M. LVRLF’s [@Pharmaceuticals: Generic] market capitalization is $6.56M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KHTRF’s FA Score shows that 0 FA rating(s) are green whileLVRLF’s FA Score has 0 green FA rating(s).

  • KHTRF’s FA Score: 0 green, 5 red.
  • LVRLF’s FA Score: 0 green, 5 red.
According to our system of comparison, both KHTRF and LVRLF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KHTRF’s TA Score shows that 4 TA indicator(s) are bullish while LVRLF’s TA Score has 5 bullish TA indicator(s).

  • KHTRF’s TA Score: 4 bullish, 3 bearish.
  • LVRLF’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, LVRLF is a better buy in the short-term than KHTRF.

Price Growth

KHTRF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while LVRLF (@Pharmaceuticals: Generic) price change was +32.08% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.26%. For the same industry, the average monthly price growth was +68.76%, and the average quarterly price growth was +80.82%.

Reported Earning Dates

LVRLF is expected to report earnings on Nov 03, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+6.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KHTRF($451M) has a higher market cap than LVRLF($6.56M). LVRLF YTD gains are higher at: 49.250 vs. KHTRF (29.086).
KHTRFLVRLFKHTRF / LVRLF
Capitalization451M6.56M6,880%
EBITDA69.3MN/A-
Gain YTD29.08649.25059%
P/E Ratio62.66N/A-
Revenue373MN/A-
Total Cash181MN/A-
Total Debt53.9MN/A-
FUNDAMENTALS RATINGS
KHTRF vs LVRLF: Fundamental Ratings
KHTRF
LVRLF
OUTLOOK RATING
1..100
3219
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
97
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
90100
PRICE GROWTH RATING
1..100
4945
P/E GROWTH RATING
1..100
96100
SEASONALITY SCORE
1..100
5033

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KHTRF's Valuation (72) in the null industry is in the same range as LVRLF (97). This means that KHTRF’s stock grew similarly to LVRLF’s over the last 12 months.

KHTRF's Profit vs Risk Rating (100) in the null industry is in the same range as LVRLF (100). This means that KHTRF’s stock grew similarly to LVRLF’s over the last 12 months.

KHTRF's SMR Rating (90) in the null industry is in the same range as LVRLF (100). This means that KHTRF’s stock grew similarly to LVRLF’s over the last 12 months.

LVRLF's Price Growth Rating (45) in the null industry is in the same range as KHTRF (49). This means that LVRLF’s stock grew similarly to KHTRF’s over the last 12 months.

KHTRF's P/E Growth Rating (96) in the null industry is in the same range as LVRLF (100). This means that KHTRF’s stock grew similarly to LVRLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KHTRFLVRLF
RSI
ODDS (%)
Bearish Trend 3 days ago
55%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
48%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 7 days ago
46%
Bullish Trend 3 days ago
67%
MACD
ODDS (%)
Bullish Trend 3 days ago
47%
Bullish Trend 4 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
35%
Bullish Trend 3 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
39%
Bullish Trend 3 days ago
70%
Advances
ODDS (%)
N/A
Bullish Trend 18 days ago
72%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
49%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
37%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
KHTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LVRLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCEBX9.850.20
+2.07%
Goldman Sachs Clean Energy Income A
NMGAX18.750.03
+0.16%
Neuberger Berman Mid Cap Growth A
PPQJX3.64N/A
N/A
Principal MidCap Growth III J
OCSGX7.00-0.01
-0.14%
Optimum Small-Mid Cap Growth C
VSEQX38.76-0.13
-0.33%
Vanguard Strategic Equity Inv

KHTRF and

Correlation & Price change

A.I.dvisor tells us that KHTRF and ESALF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KHTRF and ESALF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KHTRF
1D Price
Change %
KHTRF100%
N/A
ESALF - KHTRF
27%
Poorly correlated
+0.32%
OVATF - KHTRF
25%
Poorly correlated
N/A
TAK - KHTRF
22%
Poorly correlated
+1.35%
JUSHF - KHTRF
13%
Poorly correlated
-10.65%
HYPMY - KHTRF
8%
Poorly correlated
+4.58%
More

LVRLF and

Correlation & Price change

A.I.dvisor tells us that LVRLF and MCUJF have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LVRLF and MCUJF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LVRLF
1D Price
Change %
LVRLF100%
+19.28%
MCUJF - LVRLF
16%
Poorly correlated
N/A
MEDIF - LVRLF
7%
Poorly correlated
-7.67%
KHTRF - LVRLF
6%
Poorly correlated
N/A
KSPHF - LVRLF
5%
Poorly correlated
N/A
LBTSF - LVRLF
3%
Poorly correlated
N/A
More